Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients
ConclusionsPharmacokinetically-targeted dosing appears to increase everolimus tolerability. This finding may be applicable to other patient populations.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Bacterial Pneumonia | Cancer | Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Drugs & Pharmacology | Hematology | Leukemia | Lymphoma | Pneumonia | Rituxan | Study | Toxicology